Bill Buckley CNZM Hon FIPENZ

Co-Founder, Neutron Therapeutics; Founder and President, Buckley Systems, LLC

Bill is the President of Buckley Systems, a global leader in high technology manufacturing of precision electromagnets, particle accelerator systems, ion beam physics hardware and high vacuum equipment. The end users for this technology include semiconductor equipment manufacturers, physics research laboratories and the medical industry. Bill has led the design & manufacturing teams at Buckley Systems since the Company’s inception in the 1980’s and has built close relationships with key customers around the globe. Bill’s achievements include winning the New Zealand Entrepreneur of the Year award in 2011 and being made a Companion of the New Zealand Order of Merit in 2013 for services to technology, business and motorsport.

Ted Smick

Co-Founder and Chief Technology Officer, Neutron Therapeutics

Ted has been designing and commercializing accelerator-based technologies since the early 1980’s. These have included electrostatic tandems designed for up to 3MV for materials modification and accelerator based analytical techniques, as well as extremely high-current oxygen implanters for SIMOX material production. In addition to this world-class technical expertise, he brings decades of experience managing rapid equipment development R&D teams from concept to commercialization including the Applied Materials Quantum-X Implanter. He holds 22 patents in the area of ion implantation and most recently was Vice President of Equipment Engineering at GT Advanced Technologies.

Alain Harrus, PhD

Chairman and Chief Executive Officer, Kateeva, Inc.

Prior to Kateeva, Alain was a Partner at Crosslink Capital, a San Francisco-based venture capital company where he led the firm’s semiconductor and energy technology investment activities. Before turning to venture capital, Alain developed breakthrough process technologies that kept semiconductor manufacturers on track with Moore’s Law — first as a research scientist at Bell Laboratories, later as Chief Technology Officer at Novellus Systems — now part of Lam Research. As an investor, Alain focused on early-stage science-based hardware companies developing challenging technologies. An engaged Board member, he advised executive teams on strategic growth initiatives, particularly technology roadmap development, product and commercialization strategies, and infrastructure, as well as fund-raising, valuation and exits.

Noah Smick, PhD

President & Chief Operating Officer

Noah received his PhD from the Department of Nuclear Engineering at the Massachusetts Institute of Technology (MIT) in the field of Applied Plasma Physics. Throughout his career, Dr. Smick has been working with proton accelerators, most recently at Twin Creeks Technologies and GT Advanced Technologies with his primary focus in product development and exploring potential applications for the accelerators in various industries ranging from solar cells to commercial electronics and medical applications. He has organized collaborations among a diverse set of partners to advance the prospects of practical application of proton accelerators.

Ted Smick

Chief Technology Officer

Ted has been designing and commercializing accelerator-based technologies since the early 1980’s. These have included electrostatic tandems designed for up to 3MV for materials modification and accelerator based analytical techniques, as well as extremely high-current oxygen implanters for SIMOX material production. In addition to this world-class technical expertise, he brings decades of experience managing rapid equipment development R&D teams from concept to commercialization including the Applied Materials Quantum-X Implanter. He holds 22 patents in the area of ion implantation and most recently was Vice President of Equipment Engineering at GT Advanced Technologies.

Matthew Copeland

Chief Financial Officer

Matt has more than 20 years of experience working in the pharmaceutical and biotechnology industry, supporting all aspects of finance and accounting for public and non-public companies from audit preparations, business process improvements, ERP implementations, strategic planning, M&A, fundraising and IPOs. Matt previously served as VP of Finance/CFO at IMDx, before transitioning to a consultant role in 2015. Companies he has consulted for include Sollis Pharmaceuticals, AIT, Gamida Cell Inc, Stealth BioTherapeutics and FOG Pharmaceuticals. Since 2009, he has participated in three initial public offerings and filed twelve form S-1s with the SEC. Matt holds a BS in Molecular Genetics from The Ohio State University, and an MBA from Northeastern School of Business.

Paul Eide

Vice President of Equipment Engineering

Paul has been working in the electrical and equipment engineering field for 25 years with a focus in ion implantation. Most recently he served at Vice President of Engineering at GT Advanced Technologies where he successfully managed the Hyperion Technology Group, oversaw the development of a prototype neutron source for the purpose of Boron Neutron Capture Therapy (BNCT) and developed sapphire and silicon carbide exfoliation processes.

Angel Estrada, PhD

Senior Vice President of Regulatory & Quality

Angel joined Neuron Therapeutics as its Senior VP of Regulatory Affairs and Quality Assurance in July 2023. Mr. Estrada’s career in medical devices spans almost 30 years. He came to NT after spending over seven years at Hologic, Inc. a global medical device and diagnostics company where he served as VP of International Quality and Regulatory Affairs. During his tenure at Hologic, Inc., Angel was the regulatory and quality leader for all OUS business and suppliers, including worldwide distributors and legal entities. Prior to that, he was VP of Regulatory Affairs and Quality Assurance at Zimmer-Biomet leading teams for the surgical, knee, hip, trauma and spine businesses. Other assignments included Head of Quality Systems and Regulatory Compliance roles at Kimberly-Clark Healthcare and Covidien as well as Head of Design Control/Reliability Engineering at Abbott Laboratories and Baxter Healthcare.

Mr. Estrada is a graduate of Cadiz University Engineering School in Spain, as well as holding degrees from DePaul University in Business Administration, California State Masters in Quality Assurance and Indiana State Doctorate in Technology Management Quality Systems. He and his wife Marilyn have been married for almost 30 years and they live in Brookline, MA.

Hanna Koivunoro, PhD

Chief Medical Physicist

Hanna has been working on Boron Neutron Capture Therapy (BNCT) and related modalities over her entire career, starting while a student at the University of Helsinki. She was closely involved in the successful BNCT phase I/II clinical trials that were conducted at Helsinki University Central Hospital, and was the chief medical physicist for that program. Hanna also has experience in extensive simulation and modeling of BNCT neutron sources, including plasma based neutron sources at Lawrence Berkeley National Laboratory and the neutron beam used at the FiR-1 research reactor in Finland for the patient treatments. Most recently Hanna has worked in the development of the world’s leading radiotherapy treatment planning software at Varian Medical Systems. At Neutron Therapeutics, Hanna will oversee the creation and integration of the patient-facing aspects of the neutron therapy suite.

Heikki Joensuu, MD, PhD

Chairman of the Scientific Advisory Board, Neutron Therapeutics
Research Director, Comprehensive Cancer Center, Helsinki University Hospital

Dr. Joensuu directs research carried out at the Comprehensive Cancer Center Helsinki. This includes clinical phase I to IV studies and translational research, and networking with academic research organizations and pharmaceutical companies. He is a Professor of Oncology and Radiotherapy, University of Helsinki and a Director of the Laboratory of Molecular Medicine, Biomedicum, Helsinki. He has been involved in medical research for over 20 years and has published extensively in major academic journals. Dr. Joensuu received his medical degree and PhD from the University of Turku, Finland.

Geoff Ryding, PhD

Technical Advisor

Geoff is a world leader in innovative ion implantation. He was President and CEO of Ibis Technology Corporation which was a pioneer in the field of high-current, high-energy ion implantation. Prior to that, Geoff was a founding member of Extrion Corporation (now Applied Materials and formerly Varian Semiconductor) and Nova Associates (now Axcelis Technologies). He continues to provide physics and engineering direction in the design of NT’s accelerator products based on personal experience that spans the entire history of the field.

Tetsuya Yamamoto MD, PhD

Medical Advisor

Tetsuya is a neurosurgeon with extensive experience in particle radiation therapy (both proton therapy and BNCT). His expertise includes multi-disciplinary treatment of malignant brain tumors, skull base tumors and pediatric brain tumors, as well as surgery of microvascular decompression. Tetsuya has spent much of his career at the University of Tsukuba, where he obtained both his MD and PhD in medical science. He is now an associate professor in the Faculty of Medicine and chair of the Department of Neurosurgery at the University of Tsukuba, as well as a hospital professor at the University of Tsukuba Hospital. In addition, Tetsuya is a visiting professor in the Faculty of Pharmaceutical Sciences at the Tokyo University of Science.

Feroz Agad

Advisor

Feroz is an accomplished executive, investor and entrepreneur with over 15 years experience of managing multimillion-dollar corporations in industries including healthcare, real estate, communications, tourism and information technology. By capitalizing on his business acumen, technical expertise, interpersonal skills and strategic mindset, Mr. Agad has been instrumental in penetrating new markets and achieving significant sales growth for the companies he has previously founded and managed. Mr. Agad presently sits on the board of directors at four companies and sits on three advisory boards, a committee for a non-profit humanitarian organization and a committee on education.